Showing results (431-440 of 457) with videos related to
Sort By:
Pageof 46
Health Technology Assessment (Winchester, England)|March 19, 2019
Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCTLinda Clare, Aleksandra Kudlicka, Jan R Oyebode, et al.Aging & Mental Health|April 14, 2020
Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trialClaire A Surr, Ivana Holloway, Rebecca E A Walwyn, et al.Health Technology Assessment (Winchester, England)|March 29, 2020
Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCTClaire A Surr, Ivana Holloway, Rebecca Ea Walwyn, et al.Brain : a Journal of Neurology|August 14, 2020
Functional cognitive disorder: dementia's blind spotHarriet A Ball, Laura McWhirter, Clive Ballard, et al.Journal of Alzheimer'S Disease : JAD|December 30, 2019
Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker ResearchCorinne E Fischer, Zahinoor Ismail, James M Youakim, et al.The New England Journal of Medicine|March 9, 2012
Donepezil and memantine for moderate-to-severe Alzheimer's diseaseRobert Howard, Rupert McShane, James Lindesay, et al.BMC Public Health|November 1, 2018
Protocol for the IDEAL-2 longitudinal study: following the experiences of people with dementia and their primary carers to understand what contributes to living well with dementia and enhances active lifeBarbora Silarova, Sharon M Nelis, Rosalie M Ashworth, et al.Trials|July 28, 2009
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCTRob Jones, Bart Sheehan, Patrick Phillips, et al.The Journal of Prevention of Alzheimer'S Disease|April 18, 2026
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control dataBjoern O Schelter, Helen Shiells, Serena Lo, et al.Age and Ageing|November 16, 2020
Mild cognitive impairment: the Manchester consensusRoss A Dunne, Dag Aarsland, John T O'Brien, et al.Pageof 46